we projected that pneumocystis carinii pneumonia and other pulmonary complications would account for the largest share ( over 40 % ) of aids medical costs , and that azt therapy and medication would account for more than 25 % of total arc/aids treatment costs by 1991 .
C0043474
azt
C0001175
aids